Unpacking the Atopic Dermatitis Burden of Disease With Patients and Families

EP: 1.Updates in Pediatric Atopic Dermatitis

EP: 2.Pathophysiology and Role of Type 2 Inflammation in Pediatric Atopic Dermatitis

EP: 3.Talking to Patients and Families About Type 2 Inflammatory Conditions

Now Viewing

EP: 4.Unpacking the Atopic Dermatitis Burden of Disease With Patients and Families

EP: 5.Unique Challenges in Managing Atopic Dermatitis in Pediatric Patients

EP: 6.New Nonsteroid Topical Treatments for Pediatric Atopic Dermatitis: Topical Ruxolitinib

EP: 7.New Nonsteroid Topical Treatments for Pediatric Atopic Dermatitis: Topical Roflumilast

EP: 8.New Nonsteroid Topical Treatments for Pediatric Atopic Dermatitis: Topical Tapinarof

EP: 9.New Systemic Therapies for Pediatric Atopic Dermatitis: Dupilumab and IL-13 Inhibitors

EP: 10.Understanding and Treating Pediatric AD Inside and Out

EP: 11.New Systemic Therapies for Pediatric Atopic Dermatitis: Nemolizumab and Oral JAK Inhibitors

EP: 12.Future Directions for Pediatric Atopic Dermatitis Management and Research

Video content above is prompted by the following:

• Based on your interactions with patients, how would you characterize the burden of disease (both mentally and physically) of atopic dermatitis for both pediatric patients and their caregivers?
• How do you approach the psychosocial impact of atopic dermatitis on pediatric patients and their families, and how does it influence treatment selection?